Recurrent Liver Allograft Injury in Patients With Donor-Derived Malignancy Treated With Immunosuppression Cessation and Retransplantation.

Brian T LeeNaveen GanjooM Isabel FielJackie F HechtmanSuparna A SarkarLeona Kim-SchlugerSander S FlormanThomas D Schiano

Published in: American journal of clinical pathology (2022)

Clinicians should be aware of a potentially increased risk of rejection and recurrent allograft failure when strategizing treatment of donor-derived malignancy with immunosuppression cessation and retransplantation.

Keyphrases

kidney transplantation
palliative care
newly diagnosed